| 09/30/2026 3:40 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/16/2026 6:54 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 6:54 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 7:04 PM | Desai Kirti (2011765) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 09/16/2026 7:07 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 09/16/2026 4:12 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 7:08 PM | Goh Keow Lin (2011759) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:04 PM | Patton Curtis L. (2011753) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:04 PM | Feike Jeffrey L. (2011766) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:05 PM | Sordillo Victor J. (2011733) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:05 PM | PODLOGAR SUSAN M (1709959) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TVGNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tevogen Bio and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/10/2026 8:19 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 2:10 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/24/2026 4:30 PM | Tevogen Bio (1860871) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/14/2026 4:16 PM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/03/2026 8:20 AM | Tevogen Bio (1860871) Filer | Form DEF 14A | |
| 07/30/2026 7:31 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/23/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form PRE 14A | |
| 07/14/2026 8:56 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 07/10/2026 4:30 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:30 PM | Feike Jeffrey L. (2011766) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:30 PM | Goh Keow Lin (2011759) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Patton Curtis L. (2011753) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | PODLOGAR SUSAN M (1709959) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:31 PM | Sordillo Victor J. (2011733) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 4:17 PM | Tevogen Bio (1860871) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/26/2026 8:18 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 06/25/2026 11:15 PM | Tevogen Bio (1860871) Filer | Form EFFECT | |
| 06/12/2026 3:59 PM | Tevogen Bio (1860871) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 05/15/2026 4:01 PM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 4:00 PM | Tevogen Bio (1860871) Filer | Form 10-K/A | |
| 04/22/2026 4:15 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 4:16 PM | Tevogen Bio (1860871) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:04 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:10 PM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 03/17/2026 3:29 PM | Flomenberg Neal (2011757) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 8:08 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 03/04/2026 8:04 AM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 8:36 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |
| 02/06/2026 2:09 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad) A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor.
This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. Click here to learn this company's name for free today |
| 01/30/2026 2:37 PM | Tevogen Bio (1860871) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/26/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form DEF 14A | |
| 01/16/2026 4:29 PM | Tevogen Bio (1860871) Filer | Form PRE 14A | |
| 12/30/2025 9:12 AM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/22/2025 4:43 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 7:47 PM | Saadi Ryan H. (2011728) Filed by Tevogen Bio (1860871) Subject | Form SCHEDULE 13D/A | |
| 12/15/2025 4:31 PM | Desai Kirti (2011765) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 5:51 PM | Saadi Ryan H. (2011728) Reporting Tevogen Bio (1860871) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 8:22 AM | Tevogen Bio (1860871) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/14/2025 8:25 AM | Tevogen Bio (1860871) Filer | Form 424B3 | |